GlassScriptPhysician profile
Joan Giordano
NPI 1144387887
$3,080.54
in general payments reported to CMS, 2019-2025
23 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $740 · 2021: $1,024 · 2022: $589 · 2023: $246 · 2024: $32.80 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $810.15 | 2020-2025 | Ozempic, Rybelsus |
| Allergan, INC. | $389.27 | 2019-2020 | |
| Abbvie INC. | $313.18 | 2021-2025 | |
| Avanir Pharmaceuticals, INC. | $272.97 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $176.64 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $174.78 | 2020-2021 | |
| Lilly USA, LLC | $145.28 | 2021-2023 | Mounjaro, Emgality, Jardiance |
| Scilex Pharmaceuticals INC. | $134.12 | 2019-2022 | |
| Nevro Corp. | $128.40 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $101.77 | 2019-2022 | |
| Inspire Medical Systems, INC. | $58.04 | 2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.17 | 2019 | |
| Alfasigma USA, INC. | $51.69 | 2021 | |
| Amarin Pharma, INC. | $47.00 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $46.73 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $44.91 | 2021 | |
| Janssen Pharmaceuticals, INC | $39.03 | 2021-2022 | |
| Shire North American Group INC | $23.37 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.18 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.87 | 2021 | |
| Itamar Medical INC | $13.76 | 2025 | Watchpatone |
| Mdd US Operations, LLC | $13.06 | 2019 | |
| Assertio Therapeutics, INC. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Giordano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.